Bo-An Li

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Venues

Cell death & disease

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Ya-Pei Wang, Shu-Wen Yang, Fan Jia, Wei Wang, Xue Xu, Yi-Xuan Wang, Jing-Feng Bi, Bo-An Li
Effect of concentration, temperature, and time on the stability of hepatitis C virus nucleic acid in serum. Microbiology spectrum (2024)
Hongbo Wang, Fang Chu, Xiao-Feng Zhang, Peng Zhang, Li-Xin Li, Yun-Long Zhuang, Xiao-Feng Niu, Xi He, Zhi-Jie Li, Ying Bai, Da Mao, Zhen-Wen Liu, Da-Li Zhang, Bo-An Li
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs. Cell death & disease 14 (1) (2023)
Hongbo Wang, Fang Chu, Xiao-Feng Zhang, Peng Zhang, Li-Xin Li, Yun-Long Zhuang, Xiao-Feng Niu, Xi He, Zhi-Jie Li, Ying Bai, Da Mao, Zhen-Wen Liu, Da-Li Zhang, Bo-An Li
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs. Cell death & disease 14 (1) (2023)
Hongbo Wang, Fang Chu, Xiao-Feng Zhang, Peng Zhang, Li-Xin Li, Yun-Long Zhuang, Xiao-Feng Niu, Xi He, Zhi-Jie Li, Ying Bai, Da Mao, Zhen-Wen Liu, Da-Li Zhang, Bo-An Li
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs. Cell death & disease 14 (1) (2023)
Hongbo Wang, Fang Chu, Xiao-Feng Zhang, Peng Zhang, Li-Xin Li, Yun-Long Zhuang, Xiao-Feng Niu, Xi He, Zhi-Jie Li, Ying Bai, Da Mao, Zhen-Wen Liu, Da-Li Zhang, Bo-An Li
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs. Cell death & disease 14 (1) (2023)
Hongbo Wang, Fang Chu, Xiao-Feng Zhang, Peng Zhang, Li-Xin Li, Yun-Long Zhuang, Xiao-Feng Niu, Xi He, Zhi-Jie Li, Ying Bai, Da Mao, Zhen-Wen Liu, Da-Li Zhang, Bo-An Li
TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs. Cell death & disease 14 (1) (2023)

Bo-An Li.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bo-An Li